escitalopram + statin

This is a combination therapy consisting of escitalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and a statin, which is a class of lipid-lowering agents. Escitalopram acts primarily by inhibiting the sodium-dependent serotonin transporter (SERT), increasing synaptic serotonin levels to treat major depressive disorder and generalized anxiety disorder[3]. Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby reducing low-density lipoprotein (LDL) cholesterol and overall cardiovascular risk[5]. This combination may be used in patients who require both mood stabilization and lipid management. Evidence suggests that escitalopram can be safely co-administered with most statins without significant pharmacokinetic interactions or increased risk of adverse effects such as myopathy[2]. Some studies suggest that combining SSRIs with statins may have additive or synergistic benefits for depression treatment outcomes[6].